UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

Journal of clinical oncology, 2005-02, Vol.23 (5), p.965-972

2005

Link zum Volltext

Verfügbarkeit prüfen

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

Annals of oncology, 2006-05, Vol.17 (5), p.866-873

2006

Link zum Volltext

Verfügbarkeit prüfen

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies

Seminars in oncology, 2004-12, Vol.31 (6 Suppl 13), p.16-35

2004

Link zum Volltext

Verfügbarkeit prüfen

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

Onkologie, 2002-12, Vol.25 (6), p.511

2002

Link zum Volltext

Verfügbarkeit prüfen

The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its interaction with PARP-inhibitors

Geburtshilfe und Frauenheilkunde, 2021, Vol.81 (6)

2021

Link zum Volltext

Verfügbarkeit prüfen

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

Bone marrow transplantation (Basingstoke), 2005-02, Vol.35 (3), p.233-241

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical Phase I Dose Escalation and Pharmacokinetic Study of High-Dose Chemotherapy with Treosulfan and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Advanced Malignancies

Clinical cancer research, 2000-11, Vol.6 (11), p.4209-4216

2000

Link zum Volltext

Verfügbarkeit prüfen

The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan

Anti-cancer drugs, 2005-11, Vol.16 (10), p.1099-1108

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 1998, Vol.42 (2), p.99-104

1998

Link zum Volltext

Verfügbarkeit prüfen

Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2003-03, Vol.31 (6), p.487-491

2003

Link zum Volltext

Verfügbarkeit prüfen

Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines

British journal of cancer, 1999-12, Vol.81 (8), p.1304-1310

1999

Link zum Volltext

Verfügbarkeit prüfen

Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer

Cancer chemotherapy and pharmacology, 2000, Vol.45 (6), p.483-488

2000

Link zum Volltext

Verfügbarkeit prüfen

Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis

Immunology, 1991-12, Vol.74 (4), p.689-695

1991

Link zum Volltext

Verfügbarkeit prüfen

Cetirizine exerts anti-inflammatory effects on human neutrophils

International archives of allergy and immunology, 1996-01, Vol.110 (1), p.52

1996

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis

Immunology, 1991-05, Vol.73 (1), p.83-87

1991

Link zum Volltext

Verfügbarkeit prüfen

Dual effect of ammonium persulfate on the generation of leukotrienes from human neutrophil granulocytes

International archives of allergy and immunology, 1996-01, Vol.110 (4), p.318

1996

Link zum Volltext

Verfügbarkeit prüfen

Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells

Oncology research, 1997, Vol.9 (9), p.485

1997

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppressive agents enhance the cytokine-induced priming of inflammatory cells

International archives of allergy and immunology, 1995-05, Vol.107 (1-3), p.259

1995

Link zum Volltext

Verfügbarkeit prüfen

Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis by Staphylococcus aureus

International archives of allergy and immunology, 1992, Vol.98 (4), p.339

1992

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502

Inflammation, 1996-02, Vol.20 (1), p.57-70

1996

Link zum Volltext

Verfügbarkeit prüfen

Interactions of cytokines and lipid mediators in acute and chronic inflammation

International archives of allergy and immunology, 1995-05, Vol.107 (1-3), p.383

1995

Link zum Volltext

Verfügbarkeit prüfen

Effect of the PAF-receptor antagonist SM-12502 on human platelets

Inflammation, 1996-02, Vol.20 (1), p.71-85

1996

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

American journal of hematology, 2011-01, Vol.86 (1), p.25-30

2011

Link zum Volltext

Verfügbarkeit prüfen

Glutamate Uptake and Release by Astrocytes Are Enhanced by Clostridium botulinum C3 Protein

The Journal of biological chemistry, 2008-04, Vol.283 (14), p.9289-9299

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Hot Spot for Microdeletions in Patients with X-linked Deafness Type 3 (DFN3) 900 kb Proximal to the DFN3 gene POU3F4

Human molecular genetics, 1996-09, Vol.5 (9), p.1229-1235

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(23)
Biological And Medical Sciences
(16)
Medical Sciences
(15)
Oncology
(12)
Immunology
(11)
Adult
(9)
Female
(9)
Middle Aged
(8)
Male
(7)
Pharmacology. Drug Treatments
(7)
Aged
(6)
Antineoplastic Agents
(6)
Allergy
(5)
Busulfan - Analogs & Derivatives
(5)
Antineoplastic Agents, Alkylating - Administration & Dosage
(4)
Busulfan - Administration & Dosage
(4)
Busulfan - Pharmacokinetics
(4)
Chemotherapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its interaction with PARP-inhibitors

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

Clinical Phase I Dose Escalation and Pharmacokinetic Study of High-Dose Chemotherapy with Treosulfan and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Advanced Malignancies

The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan

Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors

Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation

Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines

Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer

Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis

Cetirizine exerts anti-inflammatory effects on human neutrophils

Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis

Dual effect of ammonium persulfate on the generation of leukotrienes from human neutrophil granulocytes

Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells

Immunosuppressive agents enhance the cytokine-induced priming of inflammatory cells

Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis by Staphylococcus aureus

Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502

Interactions of cytokines and lipid mediators in acute and chronic inflammation

Effect of the PAF-receptor antagonist SM-12502 on human platelets

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

Glutamate Uptake and Release by Astrocytes Are Enhanced by Clostridium botulinum C3 Protein

Identification of a Hot Spot for Microdeletions in Patients with X-linked Deafness Type 3 (DFN3) 900 kb Proximal to the DFN3 gene POU3F4

Suchergebnisse filtern